Key Insights

Highlights

Treatment Research

15 treatments under study, led by Suxamethonium Aguettant 10 Mgml Solution Injectable En Seringue Préremplie

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Suxamethonium Aguettant 10 Mgml Solution Injectable En Seringue Préremplie1
  • Paracetamol B Braun 10 Mgml Solution Pour Perfusion1
  • Topalgic 100 Mgml Solution Buvable1
  • Nalbuphine Renaudin 20 Mg2 Ml Solution Injectable1
  • Morphine Chlorhydrate Lavoisier 10 Mgml Solution Injectable1

Active Sponsors

  • Centre Hospitalier Universitaire De Nantes1

Activity Timeline